Novartis
NVS
925 hedge funds and large institutions have $21.4B invested in Novartis in 2015 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 335 increasing their positions, 349 reducing their positions, and 53 closing their positions.
0.03% less ownership
Funds ownership: 9.84% → 9.81% (-0.03%)
2% less call options, than puts
Call options by funds: $69.6M | Put options by funds: $71M
4% less repeat investments, than reductions
Existing positions increased: 335 | Existing positions reduced: 349
2% less funds holding
Funds holding: 943 → 925 (-18)
3% less funds holding in top 10
Funds holding in top 10: 61 → 59 (-2)
7% less capital invested
Capital invested by funds: $22.9B → $21.4B (-$1.51B)
19% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$337M |
| 2 |
State Street
Boston,
Massachusetts
|
+$331M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$331M |
| 4 |
IC
Institutional Capital
Chicago,
Illinois
|
+$227M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$148M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$398M |
| 2 |
Dodge & Cox
San Francisco,
California
|
-$223M |
| 3 |
Primecap Management
Pasadena,
California
|
-$131M |
| 4 |
BG
Bahl & Gaynor
Cincinnati,
Ohio
|
-$85M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$62.4M |
NVS Hedge Fund Activity: Q3 2015 in Review
925 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2015, worth a combined $21.4B — down 6.6% from $22.9B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of NVS and 43 opened new positions — a net loss of 10 holders — while 349 trimmed existing stakes and 335 added.
The largest buyer was Franklin Resources, adding an estimated $337M. The largest seller was Fidelity Investments, cutting an estimated $398M.
- 925 institutional investors held Novartis (NVS) as of Q3 2015, down from 943 in Q2 2015.
- Funds reported $21.4B of Novartis stock for Q3 2015, down 6.6% quarter-over-quarter.
- 43 funds opened new Novartis positions in Q3 2015 and 53 closed out, a net change of -10 holders.
- The largest Novartis buyer in Q3 2015 was Franklin Resources, an estimated $337M added.
- The largest Novartis seller in Q3 2015 was Fidelity Investments, an estimated $398M sold.
Based on aggregated 13F filings for Q3 2015.